• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium

tetano

Editor, Senior Moderator
Nat Commun


. 2020 Oct 12;11(1):5139.
doi: 10.1038/s41467-020-18781-2.
Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium


Satria P Sajuthi[SUP] 1 [/SUP], Peter DeFord[SUP] 1 [/SUP], Yingchun Li[SUP] 1 [/SUP], Nathan D Jackson[SUP] 1 [/SUP], Michael T Montgomery[SUP] 1 [/SUP], Jamie L Everman[SUP] 1 [/SUP], Cydney L Rios[SUP] 1 [/SUP], Elmar Pruesse[SUP] 1 [/SUP], James D Nolin[SUP] 1 [/SUP], Elizabeth G Plender[SUP] 1 [/SUP], Michael E Wechsler[SUP] 2 [/SUP], Angel C Y Mak[SUP] 3 [/SUP], Celeste Eng[SUP] 3 [/SUP], Sandra Salazar[SUP] 3 [/SUP], Vivian Medina[SUP] 4 [/SUP], Eric M Wohlford[SUP] 3 5 [/SUP], Scott Huntsman[SUP] 3 [/SUP], Deborah A Nickerson[SUP] 6 7 8 [/SUP], Soren Germer[SUP] 9 [/SUP], Michael C Zody[SUP] 9 [/SUP], Gon?alo Abecasis[SUP] 10 [/SUP], Hyun Min Kang[SUP] 10 [/SUP], Kenneth M Rice[SUP] 11 [/SUP], Rajesh Kumar[SUP] 12 [/SUP], Sam Oh[SUP] 3 [/SUP], Jose Rodriguez-Santana[SUP] 4 [/SUP], Esteban G Burchard[SUP] 3 13 [/SUP], Max A Seibold[SUP] 14 15 16 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, an emerging virus that utilizes host proteins ACE2 and TMPRSS2 as entry factors. Understanding the factors affecting the pattern and levels of expression of these genes is important for deeper understanding of SARS-CoV-2 tropism and pathogenesis. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci for both ACE2 and TMPRSS2, that vary in frequency across world populations. We find TMPRSS2 is part of a mucus secretory network, highly upregulated by type 2 (T2) inflammation through the action of interleukin-13, and that the interferon response to respiratory viruses highly upregulates ACE2 expression. IL-13 and virus infection mediated effects on ACE2 expression were also observed at the protein level in the airway epithelium. Finally, we define airway responses to common coronavirus infections in children, finding that these infections generate host responses similar to other viral species, including upregulation of IL6 and ACE2. Our results reveal possible mechanisms influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes.
 
Back
Top Bottom